AngioDynamics ANGO Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's total liabilities & equity?
- AngioDynamics (ANGO) reported total liabilities & equity of $260.68M in Q4 2025.
- How has AngioDynamics's total liabilities & equity changed year-over-year?
- AngioDynamics's total liabilities & equity decreased by 8.7% year-over-year, from $285.42M to $260.68M.
- What is the long-term trend for AngioDynamics's total liabilities & equity?
- Over 4 years (2021 to 2025), AngioDynamics's total liabilities & equity has grown at a -16.0% compound annual growth rate (CAGR), from $561.44M to $280.14M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.